<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Consilium Medicum</journal-id><journal-title-group><journal-title xml:lang="en">Consilium Medicum</journal-title><trans-title-group xml:lang="ru"><trans-title>Consilium Medicum</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Consilium Medicum</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-1753</issn><issn publication-format="electronic">2542-2170</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">96616</article-id><article-id pub-id-type="doi">10.26442/20751753.2021.11.201146</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Abuse of medications for the treatment of migraines: results of an online survey</article-title><trans-title-group xml:lang="ru"><trans-title>Избыточное потребление лекарственных средств для купирования головной боли при мигрени: результаты интернет-опроса</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8437-7205</contrib-id><name-alternatives><name xml:lang="en"><surname>Koval'chuk</surname><given-names>Nadezhda A.</given-names></name><name xml:lang="ru"><surname>Ковальчук</surname><given-names>Надежда Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Graduate Student</p></bio><bio xml:lang="ru"><p>аспирант каф. нервных болезней и нейрохирургии Института клинической медицины им. Н.В. Склифософского</p></bio><email>kowalchuk.n.a@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2561-5944</contrib-id><name-alternatives><name xml:lang="en"><surname>Shagbazian</surname><given-names>Anait E.</given-names></name><name xml:lang="ru"><surname>Шагбазян</surname><given-names>Анаит Эдуардовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Graduate Student</p></bio><bio xml:lang="ru"><p>аспирант каф. нервных болезней и нейрохирургии Института клинической медицины им. Н.В. Скли- фософского</p></bio><email>kowalchuk.n.a@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3833-532X</contrib-id><name-alternatives><name xml:lang="en"><surname>Tabeeva</surname><given-names>Giuzial R.</given-names></name><name xml:lang="ru"><surname>Табеева</surname><given-names>Гюзяль Рафкатовна</given-names></name></name-alternatives><address><country country="RO">Romania</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Prof.</p></bio><bio xml:lang="ru"><p>д-р мед. наук, проф. каф. нервных болезней и нейрохирургии Института клинической медицины им. Н.В. Склифософского</p></bio><email>kowalchuk.n.a@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Sechenov First Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-11-15" publication-format="electronic"><day>15</day><month>11</month><year>2021</year></pub-date><volume>23</volume><issue>11</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>847</fpage><lpage>851</lpage><history><date date-type="received" iso-8601-date="2022-01-17"><day>17</day><month>01</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-01-17"><day>17</day><month>01</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://consilium.orscience.ru/2075-1753/article/view/96616">https://consilium.orscience.ru/2075-1753/article/view/96616</self-uri><abstract xml:lang="en"><p><bold>Background. </bold>The abuse of headache medications is an important factor in the formation of drug-induced headache.</p> <p><bold>Aim. </bold>To determine the prevalence and nature of drug use among patients with migraine and chronic cephalgic syndrome.</p> <p><bold>Materials and methods. </bold>An Internet survey was conducted among 1598 Internet users, as well as through social networks (Instagram, Facebook, VK) using Google Forms.</p> <p><bold>Results. </bold>60% of respondents with chronic headache and migraine symptoms did not have a reliable diagnosis. More than 70% of patients choose a drug for pain relief on their own and 62.7% take the drug in every headache attack.</p> <p><bold>Conclusion. </bold>Among patients with chronic headaches and migraines, there is a high percentage of people abusing symptomatic drugs, which indicates a high risk of drug-induced headache formation.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование. </bold>Чрезмерное использование средств для купирования головной боли является важным фактором формирования лекарственно-индуцированной головной боли.</p> <p><bold>Цель. </bold>Выявить распространенность и паттерны использования лекарственных препаратов среди пациентов с мигренью и хроническим течением цефалгического синдрома.</p> <p><bold>Материалы и методы. </bold>Проведен интернет-опрос среди 1598 пользователей сети Интернет, а также посредством социальных сетей (Instagram, Facebook, VK) с использованием Google Forms.</p> <p><bold>Результаты. </bold>У 60% респондентов с хронической головной болью и симптомами мигрени не установлен достоверный диагноз. Более 70% пациентов выбирают препарат для купирования болевого синдрома самостоятельно и в 62,7% принимают препарат в каждый приступ головной боли.</p> <p><bold>Заключение. </bold>Среди пациентов с хроническими головными болями при мигрени отмечается высокий процент лиц, злоупотребляющих симптоматическими средствами, что говорит о высоком риске формирования лекарственно-индуцированной головной боли.</p></trans-abstract><kwd-group xml:lang="en"><kwd>chronic headache</kwd><kwd>excessive drug consumption</kwd><kwd>medication-overuse headache</kwd><kwd>migraine</kwd><kwd>self-medication</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>хроническая головная боль</kwd><kwd>избыточное потребление лекарств</kwd><kwd>лекарственно-индуцированная головная боль</kwd><kwd>мигрень</kwd><kwd>самолечение</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Diener HC, Holle D, Solbach K, Gaul C. Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol. 2016;12:575-83. DOI:10.1038/nrneurol.2016.124</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol. 2010;9:391-401. DOI:10.1016/S1474-4422(10)70008-9</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders ICHD-3, 3rd edition. Cephalalgia. 2018;38:1-211.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Westergaard ML, Hansen EH, Glümer C, et al. Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia. 2014;34(6):409-25. DOI:10.1177/0333102413512033</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Aaseth K, Grande RB, Kvaerner KJ, et al. Prevalence of secondary chronic headaches in a population-based sample of 30–44-year-old persons. The Akershus study of chronic headache. Cephalalgia. 2008;28:705-13. DOI:10.1111/j.1468-2982.2008.01577.x</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Ayzenberg I, Katsarava Z, Sborowski A, et al. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia. 2012;32(5):373-81. DOI:10.1177/0333102412438977, PMID: 22395797</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Find NL, Terlizzi R, Munksgaard SB, et al. Medication overuse headache in Europe and Latin America: general demographic and clinical characteristics, referral pathways and national distribution of painkillers in a descriptive, multinational, multicenter study. J Headache Pain. 2015;17:20. DOI:10.1186/s10194-016-0612-2, PMID: 26957090, PMCID: PMC4783306</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Bendtsen L, Munksgaard S, Tassorelli C, et al. Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia. 2014;34(6):426-33. DOI:10.1177/0333102413515338, PMID: 24322480</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Schwedt TJ, Hentz JG, Sahai-Srivastava S, et al. Headache characteristics and burden from chronic migraine with medication overuse headache: cross-sectional observations from the Medication Overuse Treatment Strategy trial. Headache. 2021;61(2):351-62. DOI:10.1111/head.14056, PMID: 33432635</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Schwedt TJ, Buse DC, Argoff CE, et al. Medication Overuse and Headache Burden Results From the CaMEO Study. Neurol Clin Pract. 2021;11(3):216-26. DOI:10.1212/CPJ.0000000000001037</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Katsarava Z, Muessig M, Dzagnidze A, et al. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia. 2005;25(1):12-5. DOI:10.1111/j.1468-2982.2004.00789.x, PMID: 15606564</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Diener HC, Dodick D, Evers S, et al. Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol. 2019;18(9):891-902. DOI:10.1016/S1474-4422(19)30146-2, PMID: 31174999</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Lipton RB, Dodick D, Sadovsky R, et al. A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology. 2003;61(3):375-82. DOI:10.1212/01.wnl.0000078940.53438.83, PMID: 12913201</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Vandenbussche N, Laterza D, Lisicki M, et al. Medication-overuse headache: a widely recognized entity amidst ongoing debate. J Headache Pain. 2018;19(1):50. DOI:10.1186/s10194-018-0875-x, PMID: 30003412, PMCID: PMC6043466</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Мербаум П.А., Табеева Г.Р., Сергеев А.В. Лекарственно-индуцированная головная боль: анализ терапевтических стратегий. Неврология, нейропсихиатрия, психосоматика. 2020;12(4):25-31 [Merbaum PA, Tabeeva GR, Sergeev AV. Drug-induced headache: an analysis of therapeutic strategies. Nevrologiia, neiropsikhiatriia, psikhosomatika. 2020;12(4):25-31 (in Russian)]. DOI:10.14412/2074-2711-2020-4-25-31</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Rapoport AM. Medication overuse headache: awareness, detection and treatment. CNS Drugs. 2008;22:995-1004. DOI:10.2165/0023210-200822120-00003</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Brusa P, Allais G, Scarinzi C, et al. Self-medication for migraine: A nationwide cross-sectional study in Italy. PLoS One. 2019;14(1):e0211191. DOI:10.1371/journal.pone.0211191, PMID: 30673780, PMCID: PMC6343913</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Mehuys E, Paemeleire K, Van Hees T, et al. Self-medication of regular headache: a community pharmacy-based survey. Eur J Neurol. 2012;19:1093-9. DOI:10.1111/j.1468-1331.2012.03681.x</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Hedenrud T, Babic N, Jonsson P. Medication overuse headache: selfperceived and actual knowledge among pharmacy staff. Headache. 2014;54:1019-25. DOI:10.1111/head.12350</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Carlsen LN, Westergaard ML, Bisgaard M, et al. National awareness campaign to prevent medication-overuse headache in Denmark. Cephalalgia. 2018;38(7):1316-25. DOI:10.1177/0333102417736898</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Westergaard ML, Hansen EH, Glumer C, Jensen RH. Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse. Eur J Clin Pharmacol. 2015;71:851-60. DOI:10.1007/s00228-015-1858-3</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Brusa P, Allais G, Scarinzi C, et al. Self-medication for migraine: A nationwide cross-sectional study in Italy. PLoS One. 2019;14(1):e0211191. DOI:10.1371/journal.pone.0211191, PMID: 30673780, PMCID: PMC6343913</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Negro A, Curto M, Lionetto L, et al. A critical evaluation on MOH current treatments. Curr Treat Options Neurol. 2017;19:32. DOI:10.1007/s11940-017-0465-2</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Westergaard ML, Glümer C, Hansen EH, Jensen RH. Medication overuse, healthy lifestyle behaviour and stress in chronic headache: results from a population-based representative survey. Cephalalgia. 2016;36:15-28. DOI:10.1177/0333102415578430</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Rossi P, Di Lorenzo C, Faroni J, et al. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia. 2006;26:1097-105. DOI:10.1111/j.1468-2982.2006.01175.x</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Jonsson P, Linde M, Hensing G, Hedenrud T. Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache. J Headache Pain. 2012;13:281-90. DOI:10.1007/s10194-012-0432-y</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Bekkelund SI, Salvesen R. Patient satisfaction with a neurological specialist consultation for headache. Scand J Prim Health Care. 2002;20:157-60. DOI:10.1080/028134302760234609</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Lai JT, Dereix JD, Ganepola RP, et al. Should we educate about the risks of medication overuse headache? J Headache Pain. 2014;15:10. DOI:10.1186/1129-2377-15-10</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Grande RB, Aaseth K, Benth JS, et al. Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol. 2011;18:129-37. DOI:10.1111/j.1468-1331.2010.03094.x</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Fritsche G, Frettlöh J, Hüppe M, et al. Prevention of medication overuse in patients with migraine. Pain. 2010;151:404-13. DOI:10.1016/j.pain.2010.07.032</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Kristoffersen ES, Straand J, Vetvik KG, et al. Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial. J Neurol Neurosurg Psychiatry. 2015;86:505-12. DOI:10.1136/jnnp-2014-308548</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Rossi P, Faroni JV, Nappi G. Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol. 2011;18:396-401. DOI:10.1111/j.1468-1331.2010.03157.x</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Lagman-Bartolome AM, Lawler V, Lay C. Headache education active-waiting directive: a program to enhance well-being during long referral wait times. Headache. 2018;58:109-17. DOI:10.1111/head.13194</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Шагбазян А.Э., Ковальчук Н.А., Табеева Г.Р. Роль образовательных программ в ведении пациентов с медикаментозно-индуцированной головной болью. Неврология, нейропсихиатрия, психосоматика. 2021;13(3):27-33 [Shagbazyan AE, Kovalchuk NA, Tabeeva GR. Role of educational programs in management of patients with medicationoveruse headache. Nevrologiia, neiropsikhiatriia, psikhosomatika. 2021;13(3):27-33 (in Russian)]. DOI:10.14412/2074-2711-2021-3-27-33</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Diener HC, Holle D, Dresler T, Gaul C. Chronic headache due to overuse of analgesics and anti-migraine agents. Dtsch Arztebl Int. 2018;115:365-70. DOI:10.3238/arztebl.2018.0365</mixed-citation></ref></ref-list></back></article>
